Home » Topics » Regulatory

Regulatory
RSS

FDA approves shorter treatment claim for Mentax

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

SangStat signs ciclosporin agreement with Amgen

Dec. 8, 1997

Oncaspar approved in Canada

Dec. 5, 1997

Gensia Laboratories receives generic approval

Dec. 5, 1997

Intermittent therapy with 5-HT reuptake inhibitor effective for dysphoric PMS

Dec. 3, 1997

Imitrex Nasal Spray now available in U.S.

Dec. 2, 1997

Muse approved in U.K.

Dec. 2, 1997

Recombinant IFN-beta-1a from Ares-Serono reduces relapses, delays progression in MS

Dec. 2, 1997

FDA approves Gensia Laboratories' generic bumetanide injection

Dec. 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.